Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Centauri Therapeutics
    24 February 2026

    Centauri Therapeutics extends Series A to £30M with £6M investment from AMR Action Fund to support progression of lead clinical candidate

    Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead of first in-human clinical trials to target Gram-negative bacterial infectionsInvestment from the world’s largest venture capital fund focused exclusively on antimicrobial therapeutics and diagnostics extend...

    Headshots of Dr Kate Atkin wearing a red jacket and Dr Terri simpkin in a black top, text reads: Imposter Phenomenon Awareness Day 27th February. With two masks on a purple background
    23 February 2026

    Announcing the inaugural Imposter Phenomenon Awareness Day

    Dr Kate Atkin and Dr Terri Simpkin are launching the inaugural International Imposter Phenomenon Awareness Day on Friday 27th February. Why phenomenon and not Syndrome? Because words matter and they can give you power to change or take it away. ...

    Syndex Bio Logo
    24 February 2026

    Syndex Bio unveils mcPCR Technology at AGBT 2026 following $15.5M seed financing

    •    mcPCR enables precise copying of DNA methylation during DNA amplification, overcoming a fundamental limitation of PCR, and unlocks new opportunities for sensitive detection of cancer, chronic disease, and in basic research•    Launch follows ...

    Loughborough Sport’s performance laboratory
    23 February 2026

    Loughborough University and Science in Sport (SiS) extend partnership in elite sport and performance nutrition

    Loughborough and Blackburn, UK, 23 February 2026: Loughborough University and Science in Sport (SiS) announces a renewed three-year partnership, strengthening the organisations’ long-standing collaboration across elite sport and performance nutrition.The agreement with SiS, the glo...

    Qualification as the bridge between scientific proof and sustainable delivery
    23 February 2026

    Before Partnership: Why Qualification Determines Whether Innovation Can Scale

    Why early governance readiness determines whether proof can become practice

    sync passkeys accross your devices
    20 February 2026

    At last: Sync passkeys across your devices

    Be honest, when was the last time you forgot a password and ended up in that endless loop of “reset your password” emails?It’s one of the biggest frustrations of modern working life.It might finally be coming to an end! Microsoft has announced that passkeys can now be synced across your...

    Liam Taylor, CEO, Axol Bioscience
    18 February 2026

    Axol Bioscience acquires ophthalmology business from Newcells Biotech

    ·  Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models ·  Strengthens position as the leading independent provider of physiologically-relevant in vitro retinal models for ophthalmology drug discovery and safety...

    leadXpro scientists with the eProtein Discovery System
    17 February 2026

    Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins

    Partnership will deliver AI-guided end-to-end workflow to access challenging membrane protein targetsTo de-risk and shorten path to critical structural and biophysical insights that inform structure-based drug designCambridge, UK, Boston MA, USA and Villigen, Switzerland, 17 February 20...

    successfully raisKluraLabs raises £8 million in funding to accelerate the rollout of its pioneering technology across global retail supply chains.
    17 February 2026

    KluraLabs secures £8 Million to scale packaging innovation and reduce food waste globally

    KluraLabs, The EpiCentre-based materials science company transforming food packaging in Haverhill, has successfully raised £8 million in funding to accelerate the rollout of its pioneering technology across global retail supply chains. ...

    keypassword, microsoft edge
    15 February 2026

    Finally, a fix for password chaos

    How many hours have you and your team lost to forgotten passwords, reset emails, or lockouts?Probably more than you’d like to admit.Microsoft Edge has introduced this simple but very welcome improvement…Click here to learn more: https://breathetechnology.com/blog/at-last-sync-passkeys-a...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 38
    • Page 39
    • Current page 40
    • Page 41
    • Page 42
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS